20Indexed trials
mesh condition
Multiple System Atrophy
Intelligence
Multiple System Atrophy intelligence: 20 indexed trials, 5 recruiting studies, 19 sponsors across 13 countries.
5Recruiting
19Sponsors
13Countries
Leading sponsors
University of Colorado, Denver20 recruiting
Chelsea Therapeutics10 recruiting
China Medical University Hospital10 recruiting
Fujian Medical University Union Hospital10 recruiting
Institut National de la Santé Et de la Recherche Médicale, France10 recruiting
MODAG GmbH10 recruiting
Mayo Clinic11 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)10 recruiting
Ospedale Generale Di Zona Moriggia-Pelascini10 recruiting
Queen Mary University of London11 recruiting
Rush University Medical Center10 recruiting
Samsung Medical Center10 recruiting
Geographic activity
United States9trials
Canada2trials
Australia2trials
United Kingdom2trials
France1trials
Italy1trials
Japan1trials
New Zealand1trials
South Korea1trials
Sweden1trials
Taiwan1trials
Austria1trials
Leading interventions
Autologous Mesenchymal Stem Cells1trials
CUE1 non-invasive device1trials
CUE1+ device active vs sham CUE1+ device1trials
Cerebellar repetitive transcranial magnetic stimulation1trials
CoMDA associated with Neural Net 91 classificator1trials
Droxidopa1trials
Elecsys (Roche) Abeta42, Ttau and Ptau1trials
Flutemetamol F18 Injection1trials
Fluvoxamine 100 mg QD for 5 days1trials
Home Visit Program1trials
Intravesical injection of Botulinum A toxin1trials
Lumipulse (Fujirebio) Abeta42, Ttau and Ptau1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.